Inovio pharmaceuticals reports q2 loss per share $0.83

Inovio reports second quarter 2020 financial results; provides dna medicines clinical program mid-year update.q2 loss per share $0.83.q2 revenue $267,000 versus $136,000.q2 revenue estimate $2.6 million -- refinitiv ibes data.q2 earnings per share estimate $-0.17 -- refinitiv ibes data.

INO Ratings Summary

INO Quant Ranking